Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.
about
Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and managementDietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studiesRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerMajor clinical research advances in gynecologic cancer in 2015Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published StudiesOvarian cancer epidemiology in the era of collaborative team science.A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAssociation Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.A Qualitative Study of the Barriers to and Facilitators of Smoking Cessation Among Lesbian, Gay, Bisexual, and Transgender Smokers Who Are Interested in QuittingOvarian cancer in Manitoba: trends in incidence and survival, 1992-2011.Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cellsLong-term supplementation with young coconut juice does not prevent bone loss but rather alleviates body weight gain in ovariectomized ratsNeurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trialCombined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms.The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study.Menopausal hormone therapy and ovarian cancerCancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.Ovarian mucinous adenocarcinoma with functioning stroma in postmenopausal women: aromatase and SF-1 expressionsReproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink.Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialDifferences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study.Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma.Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometryOvarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends.Cancer incidence attributable to the use of oral contraceptives and hormone therapy in Alberta in 2012.The Evaluation of the Effect of Herbal Extract on Osteoarthritis: In Vitro and In Vivo Study.Effect of Guizhifulingwan (Keishibukuryogan) on climacteric syndrome: study protocol for a randomized controlled pilot trial.Epidemiology of ovarian cancer: a review.Genetic screening for gynecological cancer: where are we heading?Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers.Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future.Obesity and Ovarian Cancer.Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.
P2860
Q26747160-AF95DFE3-5F1E-436C-9A0B-F6CE19929CC7Q26749395-F939AAF9-E98E-47AD-A353-388591B69BECQ26780387-EA94A29D-36D7-42AC-B7D2-834045708714Q28077183-0FF6C629-C39A-4FC9-9C32-A1F1ED2E1447Q29248161-D30C98F0-502F-4A23-B914-F6706C10F3B0Q30252987-C2170856-AAA5-42AD-B9D2-350C61B29086Q30276359-243B3C3D-446C-4F8E-9F9A-57D6A79AA96DQ30277016-7A8784C5-F5CC-48FA-AB67-B53A6DDB8ACBQ30277151-9C7B805C-7CC1-4F46-BF96-59AE58C40798Q33573997-319C8875-F362-459A-BF7B-7DA2FBED4264Q33611180-BFE3B9AE-BCB9-4721-8238-1B2523B98B94Q33651509-5EE3362B-F8A2-4402-ABB8-BAC403FDE2CFQ33685435-D0084256-04B3-49E0-B8B4-E382885BAEDFQ33710995-5FE23EB6-335C-43C8-AA0A-CF8D536DB13AQ33772887-277355E5-1195-40B2-AEF8-9837D7213E12Q33809605-BFF16F03-09FF-489F-A301-405B9E5F5F45Q36039829-E3E508BF-E972-4805-95BE-A44C2236F276Q36159386-6CD21506-FA95-4261-8B31-0E6911E80892Q36164444-44FC87F1-E66F-4997-BDFD-602CB9836137Q36292454-5DAFFC79-ACD0-4B11-BF3F-3EEABD6CAD0BQ36443891-68A6785D-1C17-4E94-97B0-1388ED86CD5AQ36583705-867D458C-E3F5-45BC-9A98-6696898F2758Q36609598-77CC65CC-A232-4331-A58E-3C3914DDD1A0Q36625021-21D0F27B-2F50-40E6-8B9B-B62696A95B3CQ36772925-506691B6-EDDB-446F-8CC6-BBCC6EC2B0F2Q36918178-00CE956C-FA93-428D-9CB3-3B2F8199D3B6Q36946741-4251C14F-AEE3-436F-B334-7110636B0F0DQ36971744-7E90EC02-D198-4821-AEA3-159D69C13D0EQ37138619-C0256C2E-214E-4877-A215-7530848F3704Q37234793-E3CFD540-AD33-426B-8EFE-FBA739A78D0FQ37349131-7D8DEA10-B607-4229-B516-C06B30148B1BQ37520988-9DB7115D-5254-45EA-A2DE-DE212A13580DQ37564894-9592A934-252E-42C9-AD17-949A38628156Q37715758-75B7F8E6-F66B-4DAC-9073-6A3C782DA89AQ37720438-8837529F-980C-494D-BDBD-BCFEDA7EC3CCQ38659935-B51A512C-3439-451A-9EB0-917362D11724Q38694178-3C50281A-FE88-4BE9-8A47-9E11E8C93B2FQ38753833-A832D65B-B366-4B1C-A7CC-417BBB0E47FAQ38788240-5F6203E5-14FE-446B-86ED-5E1D2EE8BBBCQ38851593-C3BD134C-75F6-4B7C-8F3A-52FDDF6C7E83
P2860
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Menopausal hormone use and ova ...... of 52 epidemiological studies.
@ast
Menopausal hormone use and ova ...... of 52 epidemiological studies.
@en
type
label
Menopausal hormone use and ova ...... of 52 epidemiological studies.
@ast
Menopausal hormone use and ova ...... of 52 epidemiological studies.
@en
prefLabel
Menopausal hormone use and ova ...... of 52 epidemiological studies.
@ast
Menopausal hormone use and ova ...... of 52 epidemiological studies.
@en
P2093
P2860
P1433
P1476
Menopausal hormone use and ova ...... of 52 epidemiological studies.
@en
P2093
Collaborative Group On Epidemiological Studies Of Ovarian Cancer
K Gaitskell
P2860
P304
P356
10.1016/S0140-6736(14)61687-1
P407
P577
2015-02-13T00:00:00Z